PMID- 34291991
OWN - NLM
STAT- MEDLINE
DCOM- 20220323
LR  - 20220413
IS  - 1936-2293 (Electronic)
IS  - 1064-1297 (Linking)
VI  - 30
IP  - 2
DP  - 2022 Apr
TI  - Verbal behavior related to drug reinforcement in polysubstance cannabis users: 
      Comparison across drugs.
PG  - 172-179
LID - 10.1037/pha0000404 [doi]
AB  - Verbal reports of drug effects are often used in behavioral pharmacology. Two 
      reports related to reinforcement are drug use (Harford, 1978; Liu et al., 2018) 
      frequency and drug preference. Anecdotally, some individuals may specify a 
      favorite/preferred drug (e.g., psilocybin) despite using another drug more 
      frequently (e.g., tobacco). Research comparing these two measures has led to 
      contradictory findings and included ratings from participants who may not have 
      experience with the rated drugs. No comparisons have been made between use 
      frequency and preference across multiple drugs in polysubstance users. To compare 
      use frequency and preference for drug classes, and examine relations across drug 
      classes, individuals reporting polysubstance use (N = 428) provided frequency and 
      preference ratings for nine drug classes. Mean ratings showed smoked tobacco, 
      alcohol, and cannabis were the most frequently used and most preferred drugs. 
      Mean ratings showed 3,4-Methylenedioxymethamphetamine (MDMA) and classic 
      hallucinogens were the least frequently used and least preferred drugs. However, 
      more divergence between use frequency and preference was observed when these 
      metrics were examined among individuals. Correlation coefficients between use 
      frequency and preference were lower than previously published literature. The 
      majority of polydrug comparisons were nonsignificant, and correlations between 
      different drug classes differed depending on whether use frequency or preference 
      was examined. Verbal reports about use frequency are likely not strongly 
      predictive of verbal reports about the same drug preference. Clinicians and 
      researchers should recognize that different verbal reports related to drug 
      reinforcement might be proxies for distinct aspects of reinforcement and should 
      consider these implications for assessment and research findings. (PsycInfo 
      Database Record (c) 2022 APA, all rights reserved).
FAU - Cox, David J
AU  - Cox DJ
AUID- ORCID: 0000-0003-4376-2104
AD  - Behavioral Pharmacology Research Unit.
FAU - Johnson, Matthew W
AU  - Johnson MW
AD  - Behavioral Pharmacology Research Unit.
LA  - eng
GR  - R01 DA032363/DA/NIDA NIH HHS/United States
PT  - Journal Article
DEP - 20210722
PL  - United States
TA  - Exp Clin Psychopharmacol
JT  - Experimental and clinical psychopharmacology
JID - 9419066
RN  - 0 (Hallucinogens)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - *Cannabis
MH  - *Hallucinogens/pharmacology
MH  - Humans
MH  - *N-Methyl-3,4-methylenedioxyamphetamine
MH  - *Substance-Related Disorders/epidemiology
MH  - Verbal Behavior
EDAT- 2021/07/23 06:00
MHDA- 2022/03/24 06:00
CRDT- 2021/07/22 12:16
PHST- 2021/07/23 06:00 [pubmed]
PHST- 2022/03/24 06:00 [medline]
PHST- 2021/07/22 12:16 [entrez]
AID - 2021-64596-001 [pii]
AID - 10.1037/pha0000404 [doi]
PST - ppublish
SO  - Exp Clin Psychopharmacol. 2022 Apr;30(2):172-179. doi: 10.1037/pha0000404. Epub 
      2021 Jul 22.